| Literature DB >> 32748318 |
Mario Mascalchi1, Maria Pia Viggiano2, Gioele Gavazzi3, Fabio Giovannelli4, Tommaso Currò4.
Abstract
Cognitive control is a critical feature in adapting our behavior to environmental and internal demands with two types of inhibition having been identified, namely the proactive and the reactive. Aiming to shed light on their respective neural correlates, we decided to focus on the cerebral activity before or after presentation of the target demanding a subject's stop as a way to separate the proactive from the reactive components associated with the tasks. Accordingly, we performed three Activation Likelihood Estimation (ALE) meta-analyses of fMRI studies exploring proactive and reactive inhibitory phases of cognitive control. For this purpose, we searched for fMRI studies investigating brain activity preceding or following target stimuli. Eight studies (291 subjects, 101 foci) were identified for the proactive analysis. Five of these studies and those previously analyzed by others (348 subjects, 199 foci) were meta-analyzed to explore the neural correlates of reactive inhibition. Overall, our results showed different networks for the two inhibitory components. Notably, we observed a contiguity between areas in the right inferior frontal gyrus pertaining to proactive inhibition and in the right middle frontal gyrus regarding reactive inhibition. These neural correlates allow proposal of a new comprehensive model of cognitive control.Entities:
Keywords: Cognitive control; Meta-analysis; Proactive inhibition; Right inferior frontal Gyrus; Right middle frontal Gyrus
Mesh:
Year: 2021 PMID: 32748318 PMCID: PMC8413163 DOI: 10.1007/s11682-020-00369-5
Source DB: PubMed Journal: Brain Imaging Behav ISSN: 1931-7557 Impact factor: 3.978
Fig. 5PRISMA flow chart of study selection
PRISMA 2009 Checklist
| Section/topic | # | Checklist item | Reported on page # |
| Title | |||
| Title | 1 | Identify the report as a systematic review, meta-analysis, or both. | 1 |
| Abstract | |||
| Structured summary | 2 | Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. | 2 |
| Introduction | |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. | 3–4 |
| Objectives | 4 | Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). | 4–5 |
| Methods | |||
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number. |
|
| Eligibility criteria | 6 | Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale. | 5–6 and Appendix 2 |
| Information sources | 7 | Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. | 5 |
| Search | 8 | Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. | 5 |
| Study selection | 9 | State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). | 5–6 and Appendix 1 |
| Data collection process | 10 | Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. | 5 |
| Data items | 11 | List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made. | 6–7 |
| Risk of bias in individual studies | 12 | Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. |
|
| Summary measures | 13 | State the principal summary measures (e.g., risk ratio, difference in means). | 6–7 |
| Synthesis of results | 14 | Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis. | 6–7 |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies). |
|
| Additional analyses | 16 | Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. |
|
| Section/topic | # | Checklist item | Reported on page # |
| Results | |||
| Study selection | 17 | Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. | 7 and Appendix 1 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations. | Appendix 2 |
| Risk of bias within studies | 19 | Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). |
|
| Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. | Appendix 2 |
| Synthesis of results | 21 | Present results of each meta-analysis done, including confidence intervals and measures of consistency. | 8–9 and Table |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15). |
|
| Additional analysis | 23 | Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). |
|
| Discussion | |||
| Summary of evidence | 24 | Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). | 9–10 |
| Limitations | 25 | Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias). | 14 |
| Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence, and implications for future research. | 15 |
| Funding | |||
| Funding | 27 | Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review. | 16 |
From: Moher et al. (2009)
For more information, visit: www.prisma-statement.org
Characteristics of studies included in the analysis
| Study | Year | Sample size | fMRI Task | Proactive | Reactive | ||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Age (mean, SD or range) | Gender (f/m) | Contrast | Foci | Contrast | Foci | |||
| Jaffard et al. |
| 14 | 23–37 | 0/14 | Event-related simple warned reaction time: subjects were instructed to respond as fast as possible by a button press once they detected the target regardless of whether it was preceded by a warning signal or not. For warned trials, the cue was presented with a variable delay (between 1100 and 1600 ms). Duration was about 38 mins. Data were analyzed with GLM | Cue vs Baseline | 3 | N.D | N.D. |
| Yanaka et al. |
| 27 | 24.1 ± 2.3; 22.8 ± 3.4 | 13/14 | Event-related Go/NoGo task. The subjects were initially presented with a central fixation cross. After a relatively long ITI of 12–14 s, the color of the fixation cross changed from white to yellow as a warning stimulus. Following a variable time period (2–6 s), a blue or red square was presented as the Go signal or NoGo signal, respectively. When the Go signal was presented, the subjects had to respond by pressing a button with their right thumb as quickly as possible. Duration was about 30 mins. Data were analyzed with GLM | Warning, vs “rest” | 10 | NoGovsGo | 5 |
| Zandbelt et al. |
| 22 | 23,5 (20–28) | 13/9 | Event-related delayed-response version of the stop-signal anticipation task: participants are instructed to respond when a moving indicator reaches a target, but to suppress a response when this moving indicator stops automatically before reaching this target. Stop-signal probability was was 0%, 24%, or 35%.Duration was about 42 mins. Data were analyzed with GLM. | Cue (0%, 24%, 35%) vs Baseline (rest) | 21 | NoGo/baseline (rest) | 7 |
| Hu et al. |
| 114 | 30.7 ± 11.0 | 64/50 | Event-related SST: go and stop trials were randomly intermixed in presentation with an inter-trial-interval of 2 s. A fixation dot appeared on screen to signal the beginning of each trial. After a fore-period varying from 1 s to 5 s, the dot became a circle – the “go” signal – prompting participants to quickly press a button. The circle disappeared at button press or after 1 s if the participant failed to respond. Duration was about 40 mins. Data were analyzed with GLM. | Unsigned prediction error | 8 | N.D. | N.D. |
| Bloemendaal et al |
| 48 | 25 young (mean age: 22.7 years, 18–29); 23 older adults (mean age: 67.6 years, range 61–74) | 20/28 | Event-related Load-Dependent Stop-Signal Anticipation Task. Information load increased with level. Stop-signal probability increased as a function of cue color. Every level contained 70 trials with 0% (green) and 270 trials with >0% (white) stopsignal probability. Duration was about 38 mins. Data were analyzed with GLM. | Cue volumes | 19 | StopSuccess > Go | 13 |
| Brevers et al. |
| 14 | 26,87* | 10/6* | Event-related Stop signal task variant: participants had to discriminate between neutral and poker-related pictures. Subjects were asked to stop their response when they heard a tone (stop-signal). Four different cue provided stop signal probability, 0% (green), 17% (yellow), 25% (orange), and 33% (red); Duration was about 40 mins. Data were analyzed with GLM | Warning stimuli | 26 | N.D. | N.D. |
| Gavazzi et al. |
| 16 | 38.3 ± 11.0 | 8/8 | Event-related Go/Nogo task: participants were asked to press a button as quickly as possible with their right index finger when a “Go” stimulus was presented and not to respond when “Nogo” stimulus was displayed. A descending series of asterisks was presented at the beginning of each trial to prepare participants to the proper GNG stimulus (“readiness” period).Duration was about 12 mins. Data were analyzed with GLM. | Warning stimuli vs Baseline (rest) | 5 | NoGo/baseline (rest) | 14 |
| Gavazzi et al |
| 36 | 30.7 ± 6.6 | 21/15 | Event-related Go/Nogo task: participants were asked to press a button as quickly as possible with their right index finger when a “Go” stimulus was presented and not to respond when “Nogo” stimulus was displayed. A descending series of points was presented at the beginning of each trial to prepare participants to the proper GNG stimulus (“readiness” period). Duration was about 12 mins. Data were analyzed with GLM. | Warning stimuli vs Baseline (rest) | 9 | NoGo/baseline (rest) | 20 |
*Data provided for the entire control group, 2 subjects were excluded from analysis
Fig. 1ALE meta-analysis map for the Proactive and Reactive Inhibition process of our data selection. The algorithm converged for Proactive process (in yellow-red) on right Insula (Ins) and extended to rIFG, left Ins, right Thalamus (Th) and bilaterally the Anterior Cingulate Cortex (ACC). The algorithm converged for Reactive process (in white-green) on the right Middle Frontal Gyrus (r-MFG), left Pre-Central Gyrus (l-PCG), medial Frontal Gyrus (m-FG) and right Inferior Parietal Lobule (r-IPL)- P < 0.05 cluster-level corrected inference using P < 0.005 uncorrected at voxel-level as the cluster-forming threshold
Results from ALE meta-analysis. Foci are reported in Talairach coordinates. BA = Brodmann’s area
| Proactive Process: ALE metanalysis computed from our study selection | ||||||
| Cluster# | Vol. (mm^3) | Ext. Val | x | y | z | Label |
| 1 | 3064 | 0.01867947 | 34 | 18 | 8 | Right Cerebrum.Sub-lobar.Insula.Gray Matter.BA 13 |
| 0.016100656 | 32 | 20 | 0 | Right Cerebrum.Sub-lobar.Insula.Gray Matter.* | ||
| 0.013882096 | 46 | 14 | 4 | Right Cerebrum.Sub-lobar.Insula.Gray Matter.BA 13 | ||
| 2 | 1888 | 0.017532656 | −30 | 22 | 6 | Left Cerebrum.Sub-lobar.Insula.Gray Matter.BA 13 |
| 0.01677453 | −28 | 16 | −2 | Left Cerebrum.Sub-lobar.Claustrum.Gray Matter.* | ||
| 3 | 1440 | 0.019304343 | 8 | −24 | 2 | Right Cerebrum.Sub-lobar.Thalamus.Gray Matter.* |
| 0.010329299 | 8 | −16 | 8 | Right Cerebrum.Sub-lobar.Thalamus.Gray Matter.Medial Dorsal Nucleus | ||
| 4 | 1120 | 0.01255372 | −8 | 10 | 40 | Left Cerebrum.Limbic Lobe.Cingulate Gyrus.Gray Matter.BA 32 |
| 0.01195102 | 6 | 14 | 38 | Right Cerebrum.Frontal Lobe.Cingulate Gyrus.Gray Matter.BA 32 | ||
| 0.009141383 | −6 | 6 | 46 | Left Cerebrum.Limbic Lobe.Cingulate Gyrus.Gray Matter.BA 24 | ||
| Reactive Process: ALE metanalysis computed from our and Simmonds et al. ( | ||||||
| Cluster# | Vol. (mm^3 | Ext. Val | x | y | z | Label |
| 1 | 3184 | 0.020494524 | 42 | 34 | 24 | Right Cerebrum.Frontal Lobe.Middle Frontal Gyrus.Gray Matter.BA 46 |
| 0.014735842 | 32 | 44 | 24 | Right Cerebrum.Frontal Lobe.Middle Frontal Gyrus.Gray Matter.BA 10 | ||
| 0.01393399 | 36 | 24 | 34 | Right Cerebrum.Frontal Lobe.Middle Frontal Gyrus.Gray Matter.BA 9 | ||
| 0.010021554 | 28 | 52 | 36 | Right Cerebrum.Frontal Lobe.Superior Frontal Gyrus.Gray Matter.BA 9 | ||
| 0.0095843645 | 26 | 46 | 32 | Right Cerebrum.Frontal Lobe.Superior Frontal Gyrus.Gray Matter.BA 9 | ||
| 2 | 2616 | 0.018389503 | 40 | −52 | 44 | Right Cerebrum.Parietal Lobe.Inferior Parietal Lobule.Gray Matter.BA 40 |
| 0.01829336 | 48 | −44 | 40 | Right Cerebrum.Parietal Lobe.Inferior Parietal Lobule.Gray Matter.BA 40 | ||
| 0.011250421 | 26 | −64 | 38 | Right Cerebrum.Parietal Lobe.Precuneus.Gray Matter.BA 7 | ||
| 3 | 2312 | 0.017564192 | −50 | −10 | 46 | Left Cerebrum.Frontal Lobe.Precentral Gyrus.Gray Matter.BA 4 |
| 0.015164279 | −38 | −18 | 48 | Left Cerebrum.Frontal Lobe.Precentral Gyrus.Gray Matter.BA 4 | ||
| 0.0087818615 | −38 | −10 | 44 | Left Cerebrum.Frontal Lobe.Precentral Gyrus.Gray Matter.BA 6 | ||
| 4 | 1856 | 0.015462176 | 36 | 18 | 4 | Right Cerebrum.Sub-lobar.Insula.Gray Matter.BA 13 |
| 0.0137887085 | 36 | 10 | −2 | Right Cerebrum.Sub-lobar.Insula.Gray Matter.BA 13 | ||
| 5 | 1712 | 0.018349858 | 2 | 16 | 44 | Right Cerebrum.Frontal Lobe.Medial Frontal Gyrus.Gray Matter.BA 6 |
| 0.010666837 | −8 | 10 | 44 | Left Cerebrum.Frontal Lobe.Medial Frontal Gyrus.Gray Matter.BA 32 | ||
| Reactive Process: ALE metanalysis computed from Simmonds et al. ( | ||||||
| Cluster# | Vol. (mm^3) | Ext. Val | x | y | z | Label |
| 1 | 2504 | 0.020474896 | 42 | 34 | 24 | Right Cerebrum.Frontal Lobe.Middle Frontal Gyrus.Gray Matter.BA46 |
| 0.013930568 | 36 | 24 | 34 | Right Cerebrum.Frontal Lobe.Middle Frontal Gyrus.Gray Matter.BA9 | ||
| 2 | 1736 | 0.014614802 | −16 | 2 | 6 | Left Cerebrum.Sub-lobar.Lentiform Nucleus.Gray Matter.Putamen |
| 3 | 1408 | 0.017052285 | −42 | −62 | −12 | Left Cerebrum.Temporal Lobe.Fusiform Gyrus.Gray Matter.BA37 |
| 4 | 1384 | 0.014383861 | −44 | −40 | 40 | Left Cerebrum.Parietal Lobe.Inferior Parietal Lobule.Gray Matter.BA 40 |
Fig. 2Conjunction and subtraction analyses of Proactive and Reactive Inhibitory process. The scale bar in red represents minimum ALE values from 0.004 to 0.011 in the conjunction analysis - Anterior Cingulate Cortex (ACC) and right Insula (r-Ins) activations. The scale bar in green represents z-values from 1 to 2.5 revealed by the contrast Reactive Inhibition > Proactive inhibition (right Middle Frontal Gyrus, r-MFG)
Fig. 3ALE meta-analysis map for the Reactive Inhibition process. The algorithm converged for our data cumulated with Simmonds et al. (2008) on the right Middle Frontal Gyrus (r-MFG), left Pre-Central Gyrus (l-PCG), medial Frontal Gyrus (m-FG) and right Inferior Parietal Lobule (r-IPL), as shown in white-green. The algorithm converged for reanalysis of Simmonds et al. (2008) data alone (in white-blue) on the right Middle Frontal Gyrus (r-MFG), the left Inferior Parietal Lobule (l-IPL), left Frontal Gyrus (l-FG) and the left Putamen (Pu) - P < 0.05 cluster-level corrected inference using P < 0.005 uncorrected at voxel-level as the cluster-forming threshold
Results from ALE meta-analysis. Foci are reported in Talairach coordinates. BA = Brodmann’s area
| Reactive Process: Original ALE metanalysis of all studies reported in Simmonds et al. ( | |||||||
|---|---|---|---|---|---|---|---|
| Region | Hem | BA | x | y | z | Vol (mm3) | ALE (×10–3) |
| Inferior/Middle frontal gyrus | R | 9/44 | 40 | 30 | 26 | 7464 | 9,21 |
| Inferior parietal lobule | R | 40 | 38 | −50 | 42 | 6808 | 8,14 |
| Superior medial wall (pre-SMA) | B | 6/32 | 2 | 18 | 40 | 3712 | 7,95 |
| Putamen/insula | L | −16 | 0 | 8 | 2624 | 6,03 | |
| Inferior parietal lobule | L | 40 | −44 | −42 | 42 | 1784 | 5,88 |
| Fusiform gyrus/posterior cerebellum | L | 19/37 | −40 | −60 | −14 | 1376 | 5,99 |
| Middle occipital gyrus | R | 19 | 44 | −72 | - 4 | 1032 | 4,67 |
| Middle frontal gyrus | R | 10 | 36 | 50 | 4 | 1016 | 5,19 |
| Middle frontal gyrus | L | 6 | −40 | 8 | 42 | 368 | 4,35 |
| Putamen/insula | R | 32 | 16 | 0 | 280 | 4,12 | |
| Superior frontal gyrus | R | 9 | 24 | 50 | 30 | 128 | 4,07 |
Fig. 4Contiguity in right pre-frontal cortex between proactive (r-IFG) and reactive (r-MFG) inhibitory processes. a - Foci meeting criteria for inclusion in the metanalysis of proactive (red sphere) and reactive (green sphere) inhibitory processes. Each foci is represented by a sphere with size proportional to the number of subjects enrolled in the study. From top to down, the two dotted white lines identify the r-MFG and the r-IFG brain regions, respectively. b - This panel illustrates the Excitatory, Inhibitory and Switch components of the P-R M. According to the model the excitatory component would be exerted by the thalamus and both Insulae, whereas the inhibitory component would recruit the r-IFG and the r-MFG for the proactive and reactive inhibitory processes, respectively. The ACC would play the role of the switch component turning the proactive network into the reactive one